Evaluation of the Unyvero i60 ITI® multiplex PCR for infected chronic leg ulcers diagnosis.


Journal

Journal of microbiological methods
ISSN: 1872-8359
Titre abrégé: J Microbiol Methods
Pays: Netherlands
ID NLM: 8306883

Informations de publication

Date de publication:
01 2020
Historique:
received: 16 05 2019
revised: 27 11 2019
accepted: 28 11 2019
pubmed: 4 12 2019
medline: 13 2 2021
entrez: 3 12 2019
Statut: ppublish

Résumé

Unyvero i60 ITI multiplex PCR (mPCR) may identify a large panel of bacteria and antibiotic resistance genes. In this study, we compared results obtained by mPCR to standard bacteriology in chronic leg ulcer (CLU) infections. A prospective study, part of the interventional-blinded randomized study "ulcerinfecte" (NCT02889926), was conducted at Saint Joseph Hospital in Paris. Fifty patients with a suspicion of infected CLU were included between February 2017 and September 2018. Conventional bacteriology and mPCR were performed simultaneously on deep skin biopsies. Staphylococcus aureus and Pseudomonas aeruginosa were the most detected pathogens. Regarding the global sensitivity, mPCR is not overcome to the standard culture. Anaerobes and slow growing bacteria were detected with a higher sensitivity rate by mPCR than standard culture. Unyvero i60 ITI multiplex PCR detected rapidly pathogenic bacteria in infected CLU especially anaerobes and slow growing bacteria and was particularly effective for patients previously treated with antibiotics.

Identifiants

pubmed: 31790779
pii: S0167-7012(19)30364-1
doi: 10.1016/j.mimet.2019.105796
pii:
doi:

Types de publication

Comparative Study Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

105796

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Sophie Reissier (S)

Clinical Microbiology Laboratory, Saint-Joseph Hospital, Paris, France. Electronic address: sophie.reissier@gmail.com.

Isabelle Lazareth (I)

Vascular Medicine and Phlebology Service, Saint-Joseph Hospital, Paris, France.

Louise Adjiman (L)

Clinical Microbiology Laboratory, Saint-Joseph Hospital, Paris, France.

Carine Couzigou (C)

Antimicrobial Stewardship Team, Saint-Joseph Hospital, Paris, France.

Barbara Vidal (B)

Antimicrobial Stewardship Team, Saint-Joseph Hospital, Paris, France.

Assaf Mizrahi (A)

Clinical Microbiology Laboratory, Saint-Joseph Hospital, Paris, France.

Jean Claude Nguyen Van (JC)

Clinical Microbiology Laboratory, Saint-Joseph Hospital, Paris, France.

Benoît Pilmis (B)

Antimicrobial Stewardship Team, Saint-Joseph Hospital, Paris, France.

Alban Le Monnier (A)

Clinical Microbiology Laboratory, Saint-Joseph Hospital, Paris, France.

Julie Lourtet-Hascoët (J)

Clinical Microbiology Laboratory, Saint-Joseph Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH